StarTribune.com
us menstrual bleeding drug fda 111309

Home | Lifestyle | Health + Wellness

FDA approves first non-hormone therapy for excessive menstrual bleeding

Last update: November 13, 2009 - 2:53 PM

WASHINGTON - Federal health officials have approved a new drug as the first non-hormonal treatment for heavy menstrual bleeding.

The Food and Drug Administration says Lysteda tablets reduce bleeding by acting on a protein that helps blood clot. The drug is made by Newport, Ky.-based Xanodyne Pharmaceuticals.

The main ingredient in the drug was first approved in 1986 as an injection for patients with hemophilia, an inheritable disease that prevents blood clotting.

The FDA warns that taking Lysteda with hormonal contraceptive drugs can increase the risk of blood clots, stroke and heart attacks. Women should only use the products together if there is a strong medical need, the agency says.

Recent Health + Wellness stories

China's health ministry investigating deaths of 2 people vaccinated for swine flu - November 13, 2009
China's health ministry investigating deaths of 2 people vaccinated for swine flu - Two people in China who received swine flu vaccinations died in the past week but at least one death appears unrelated to the vaccine and the other was being investigated. More
Pfizer pullout from Connecticut city puzzles those who lost key eminent domain case - November 13, 2009

Comment on this story   |   Be the first to comment   |  Hide reader comments

Subscribe
Shopping + Classifieds
On Sale Calendar

Know More. Save More!

Check out sales advertised in Star Tribune. This is your one stop for savings. Updated daily. Go now!
Yellow Pages

Get A Professional

Find home maintenance, car repair, legal advice, cleaning, and more in the Yellow Pages. Go now!

Win tickets to see The Hidden Cameras with Gentlemen Reg at 7th Street Entry.

Vita.mn presents The Hidden Cameras with Gentlemen Reg at 7th Street Entry on Dec. 2.

See all contests